carnitine has been researched along with Left Ventricular Hypertrophy in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was performed to evaluate the effects of L-carnitine administration on long-term left ventricular dilation in patients with acute anterior myocardial infarction." | 9.08 | Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. ( Biasco, G; Boni, L; Bruzzi, P; D'Ambrosio, G; Di Biase, M; Hugenholtz, PG; Iliceto, S; Rizzon, P; Scrutinio, D, 1995) |
| "The carnitine-associated alteration of myocardial fatty acid metabolism may be one of the molecular mechanisms underlying left ventricular hypertrophy (LVH) in essential hypertension." | 7.73 | Haplotype analysis of carnitine transporters and left ventricular mass in human essential hypertension. ( Bianchi, G; Bigatti, G; Modica, R; Stella, A; Stella, P; Tripodi, G, 2005) |
| "To determine whether propionyl-L-carnitine (PLC) administration ameliorates ventricular remodeling after myocardial infarction, we performed coronary occlusion in rats and examined the long-term effects of the drug 19-24 wk after surgery." | 7.68 | Propionyl-L-carnitine limits chronic ventricular dilation after myocardial infarction in rats. ( Anversa, P; Benatti, P; Bianchi, G; Capasso, JM; Di Paola, ED; English, E; Micheletti, R; Schiavone, A, 1993) |
| "This study was performed to evaluate the effects of L-carnitine administration on long-term left ventricular dilation in patients with acute anterior myocardial infarction." | 5.08 | Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. ( Biasco, G; Boni, L; Bruzzi, P; D'Ambrosio, G; Di Biase, M; Hugenholtz, PG; Iliceto, S; Rizzon, P; Scrutinio, D, 1995) |
| "The carnitine-associated alteration of myocardial fatty acid metabolism may be one of the molecular mechanisms underlying left ventricular hypertrophy (LVH) in essential hypertension." | 3.73 | Haplotype analysis of carnitine transporters and left ventricular mass in human essential hypertension. ( Bianchi, G; Bigatti, G; Modica, R; Stella, A; Stella, P; Tripodi, G, 2005) |
| "To determine whether propionyl-L-carnitine (PLC) administration ameliorates ventricular remodeling after myocardial infarction, we performed coronary occlusion in rats and examined the long-term effects of the drug 19-24 wk after surgery." | 3.68 | Propionyl-L-carnitine limits chronic ventricular dilation after myocardial infarction in rats. ( Anversa, P; Benatti, P; Bianchi, G; Capasso, JM; Di Paola, ED; English, E; Micheletti, R; Schiavone, A, 1993) |
| "Dilated cardiomyopathy is one of the cardinal manifestations of carnitine deficiency in children." | 1.36 | [The "big heart" of carnitine]. ( Gesuete, V; Picchio, FM; Ragni, L, 2010) |
| "Barth syndrome is an X-linked recessive condition characterized by skeletal myopathy, cardiomyopathy, proportionate short stature, and recurrent neutropenia, but with normal cognitive function." | 1.29 | Barth syndrome: clinical observations and genetic linkage studies. ( Becker, LE; Bridge, PJ; Christodoulou, J; Clarke, JT; Jay, V; Lehotay, DC; McInnes, RR; Platt, BA; Robinson, BH; Wilson, G, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voros, G | 1 |
| Ector, J | 1 |
| Garweg, C | 1 |
| Droogne, W | 1 |
| Van Cleemput, J | 1 |
| Peersman, N | 1 |
| Vermeersch, P | 1 |
| Janssens, S | 1 |
| Higuchi, T | 1 |
| Abe, M | 1 |
| Yamazaki, T | 1 |
| Okawa, E | 1 |
| Ando, H | 1 |
| Hotta, S | 1 |
| Oikawa, O | 1 |
| Kikuchi, F | 1 |
| Okada, K | 1 |
| Soma, M | 1 |
| Bhandari, S | 1 |
| Gesuete, V | 1 |
| Ragni, L | 1 |
| Picchio, FM | 1 |
| Tripodi, G | 1 |
| Modica, R | 1 |
| Stella, A | 1 |
| Bigatti, G | 1 |
| Bianchi, G | 2 |
| Stella, P | 1 |
| Jalil, MA | 1 |
| Horiuchi, M | 1 |
| Wakamatsu, M | 1 |
| Li, MX | 1 |
| Begum, L | 1 |
| Suzuki, K | 1 |
| Kobayashi, K | 1 |
| Oka, T | 1 |
| Saheki, T | 1 |
| Sakurabayashi, T | 1 |
| Miyazaki, S | 1 |
| Yuasa, Y | 1 |
| Sakai, S | 1 |
| Suzuki, M | 1 |
| Takahashi, S | 1 |
| Hirasawa, Y | 1 |
| Iliceto, S | 3 |
| Scrutinio, D | 1 |
| Bruzzi, P | 1 |
| D'Ambrosio, G | 1 |
| Boni, L | 1 |
| Di Biase, M | 1 |
| Biasco, G | 1 |
| Hugenholtz, PG | 1 |
| Rizzon, P | 2 |
| Christodoulou, J | 1 |
| McInnes, RR | 1 |
| Jay, V | 1 |
| Wilson, G | 1 |
| Becker, LE | 1 |
| Lehotay, DC | 1 |
| Platt, BA | 1 |
| Bridge, PJ | 1 |
| Robinson, BH | 1 |
| Clarke, JT | 1 |
| Micheletti, R | 1 |
| Di Paola, ED | 1 |
| Schiavone, A | 1 |
| English, E | 1 |
| Benatti, P | 1 |
| Capasso, JM | 1 |
| Anversa, P | 1 |
| Perazella, MA | 1 |
2 reviews available for carnitine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease.
Topics: Albuminuria; Anemia, Iron-Deficiency; Calcium Phosphates; Carnitine; Heart Failure; Homocysteine; Hu | 2011 |
Pharmacologic options available to treat symptomatic intradialytic hypotension.
Topics: Adrenergic Agents; Autonomic Nervous System; Caffeine; Carnitine; Ephedrine; Fludrocortisone; Hemodi | 2001 |
4 trials available for carnitine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Carnitine; Female; Humans; Hypertrophy, Left Ventricular; Kidney Failure, C | 2016 |
L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis.
Topics: Administration, Oral; Adult; Blood Pressure; Body Weight; Carnitine; Echocardiography; Female; Hemat | 2008 |
Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial.
Topics: Adult; Aged; Analysis of Variance; Carnitine; Double-Blind Method; Drug Administration Schedule; Ech | 1995 |
[Prevention of post-infarction remodelling with L-carnitine: multicenter study CEDIM (L-Carnitine digital echocardiography myocardial infarction)].
Topics: Carnitine; Double-Blind Method; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Myocardial | 1994 |
7 other studies available for carnitine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
Topics: 3-Hydroxybutyric Acid; Adaptation, Physiological; Aged; Aged, 80 and over; Aortic Valve Stenosis; Bi | 2018 |
[The "big heart" of carnitine].
Topics: Cardiomyopathy, Dilated; Carnitine; Dyspnea; Female; Heart Failure; Humans; Hypertrophy, Left Ventri | 2010 |
Haplotype analysis of carnitine transporters and left ventricular mass in human essential hypertension.
Topics: Adult; Aged; Carnitine; Carnitine O-Palmitoyltransferase; Female; Gene Frequency; Genotype; Haplotyp | 2005 |
Attenuation of cardiac hypertrophy in carnitine-deficient juvenile visceral steatosis (JVS) mice achieved by lowering dietary lipid.
Topics: Animals; Aspirin; Carnitine; Diet; Dinoprost; Disease Models, Animal; Dose-Response Relationship, Dr | 2006 |
Barth syndrome: clinical observations and genetic linkage studies.
Topics: Abnormalities, Multiple; Acids; Cardiomyopathy, Dilated; Carnitine; Diseases in Twins; Dwarfism; Ele | 1994 |
Propionyl-L-carnitine limits chronic ventricular dilation after myocardial infarction in rats.
Topics: Administration, Oral; Animals; Blood Pressure; Carnitine; Enalapril; Hypertrophy, Left Ventricular; | 1993 |
[Therapeutic action of L-carnitine in myocardial ischemia and left ventricular remodeling: clinical data].
Topics: Carnitine; Echocardiography; Humans; Hypertrophy, Left Ventricular; Myocardial Infarction; Myocardia | 1998 |